DSN1

Across TCGA pan-cancer cohorts, DSN1 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of DSN1’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where DSN1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DSN1 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

CCRCC, COAD, and LSCC are the cancer types where DSN1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DSN1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	+0.593	<.001	12	view →
COAD	Male	II,III,IV	+0.337	<.001	9	view →
LSCC	Male	II,III,IV	+0.417	<.001	8	view →
LUAD	Male	All	+0.335	<.001	8	view →
HNSC	All	IV	+0.247	<.001	8	view →
PDAC	Male	II,III,IV	−0.177	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

DSN1–CCRCC

Open the CCRCC breakdown →